Search research articles
Contact Us
Filters
Showing results (81-90 of 119) with videos related to
Page
of 12
Sort By:
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
March 8, 2005
Polar body diagnosis for hemophilia a using multiplex PCR for linked polymorphic markers
Diana Tomi, Georg Griesinger, Askan Schultze-Mosgau, et al.
Reproductive Biomedicine Online
|
May 20, 2005
Factors affecting outcome after ICSI with spermatozoa retrieved from cryopreserved testicular tissue in non-obstructive azoospermia
Konstantinos Dafopoulos, Georg Griesinger, Askan Schultze-Mosgau, et al.
Reproductive Biomedicine Online
|
May 20, 2005
Cumulative pregnancy rate after ICSI with cryopreserved testicular tissue in non-obstructive azoospermia
Konstantinos Dafopoulos, Georg Griesinger, Askan Schultze-Mosgau, et al.
Frontiers in Endocrinology
|
January 9, 2023
Prospective multicenter non-interventional real-world study to assess the patterns of use, effectiveness and safety of follitropin delta in routine clinical practice (the PROFILE study)
Christophe Blockeel, Georg Griesinger, Rocco Rago, et al.
Human Reproduction Open
|
January 11, 2024
Double vitrification and warming does not compromise the chance of live birth-a potential invalid conclusion
Laszlo Nanassy, Beate Schoepper, Askan Schultze-Mosgau, et al.
Reproductive Biomedicine Online
|
March 6, 2012
Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH
Basil C Tarlatzis, Georg Griesinger, Arthur Leader, et al.
Plos One
|
March 8, 2016
Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol
Georg Griesinger, Pierre J M Verweij, Davis Gates, et al.
Reproductive Biology and Endocrinology : RB&E
|
May 12, 2021
Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007-2017)
Human Fatemi, Wilma Bilger, Deborah Denis, et al.
The Cochrane Database of Systematic Reviews
|
November 12, 2010
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles
Mohamed Afm Youssef, Fulco Van der Veen, Hesham G Al-Inany, et al.
Fertility and Sterility
|
July 19, 2015
Intercycle variability of the ovarian response in patients undergoing repeated stimulation with corifollitropin alfa in a gonadotropin-releasing hormone antagonist protocol
Luk Rombauts, Cornelis B Lambalk, Askan Schultze-Mosgau, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 119) with videos related to
Sort By:
Page
of 12
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
March 8, 2005
Polar body diagnosis for hemophilia a using multiplex PCR for linked polymorphic markers
Diana Tomi, Georg Griesinger, Askan Schultze-Mosgau, et al.
Reproductive Biomedicine Online
|
May 20, 2005
Factors affecting outcome after ICSI with spermatozoa retrieved from cryopreserved testicular tissue in non-obstructive azoospermia
Konstantinos Dafopoulos, Georg Griesinger, Askan Schultze-Mosgau, et al.
Reproductive Biomedicine Online
|
May 20, 2005
Cumulative pregnancy rate after ICSI with cryopreserved testicular tissue in non-obstructive azoospermia
Konstantinos Dafopoulos, Georg Griesinger, Askan Schultze-Mosgau, et al.
Frontiers in Endocrinology
|
January 9, 2023
Prospective multicenter non-interventional real-world study to assess the patterns of use, effectiveness and safety of follitropin delta in routine clinical practice (the PROFILE study)
Christophe Blockeel, Georg Griesinger, Rocco Rago, et al.
Human Reproduction Open
|
January 11, 2024
Double vitrification and warming does not compromise the chance of live birth-a potential invalid conclusion
Laszlo Nanassy, Beate Schoepper, Askan Schultze-Mosgau, et al.
Reproductive Biomedicine Online
|
March 6, 2012
Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH
Basil C Tarlatzis, Georg Griesinger, Arthur Leader, et al.
Plos One
|
March 8, 2016
Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol
Georg Griesinger, Pierre J M Verweij, Davis Gates, et al.
Reproductive Biology and Endocrinology : RB&E
|
May 12, 2021
Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007-2017)
Human Fatemi, Wilma Bilger, Deborah Denis, et al.
The Cochrane Database of Systematic Reviews
|
November 12, 2010
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles
Mohamed Afm Youssef, Fulco Van der Veen, Hesham G Al-Inany, et al.
Fertility and Sterility
|
July 19, 2015
Intercycle variability of the ovarian response in patients undergoing repeated stimulation with corifollitropin alfa in a gonadotropin-releasing hormone antagonist protocol
Luk Rombauts, Cornelis B Lambalk, Askan Schultze-Mosgau, et al.
Page
of 12